Market Insights Health OTC Pharmaceuticals

Skin Treatment - Japan

Japan

In Japan, the revenue generated in the Skin Treatment market market in 2024 amounts to US$1.16bn.
It is projected that the market will experience an annual growth rate of 5.55% (CAGR 2024-2029).
When compared to other countries around Worldwide, the in the United States generates the highest revenue in the market, with US$4,184.00m in 2024.
In terms of per capita figures, each person in Japan generates US$9.43 in revenue in 2024.
In Japan, there is a growing trend towards using traditional Japanese ingredients and techniques in skin treatment products for the OTC Pharmaceuticals market.

Key regions: Australia, Brazil, Canada, China, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Skin Treatment market in Japan has been experiencing significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences: Japanese consumers are increasingly prioritizing skincare and investing in high-quality skin treatment products. This shift in consumer behavior can be attributed to several factors. Firstly, there is a growing awareness of the importance of skincare as part of a healthy lifestyle. Japanese consumers are becoming more educated about the benefits of using skincare products to maintain youthful and radiant skin. Secondly, there is a strong emphasis on self-care and self-improvement in Japanese culture. Skincare is seen as a way to enhance one's appearance and boost self-confidence. Lastly, the influence of social media and beauty influencers has played a significant role in shaping consumer preferences. Japanese consumers are exposed to a wide range of skincare trends and are willing to try new products and treatments to achieve their desired results.

Trends in the market: One of the key trends in the Skin Treatment market in Japan is the increasing demand for natural and organic products. Japanese consumers are becoming more conscious of the ingredients used in skincare products and are opting for products that are free from harmful chemicals and additives. This trend is driven by a desire for healthier and more sustainable options. Manufacturers are responding to this demand by developing innovative formulations that harness the power of natural ingredients.Another trend in the market is the rise of multi-step skincare routines. Japanese consumers are known for their meticulous skincare rituals, which often involve multiple products and steps. This trend has led to an increase in the demand for specialized skin treatment products that target specific concerns such as anti-aging, hydration, and brightening. Manufacturers are introducing a wide range of products to cater to these specific needs, including serums, essences, and masks.

Local special circumstances: Japan has a unique skincare culture that sets it apart from other countries. The country has a long history of beauty rituals and traditional skincare practices, such as the use of rice bran and green tea. These cultural influences have shaped the preferences and expectations of Japanese consumers when it comes to skincare. Local brands that incorporate traditional ingredients and techniques into their products have gained popularity in the market.

Underlying macroeconomic factors: The Skin Treatment market in Japan is also influenced by macroeconomic factors. The country has a large aging population, which has led to a growing demand for anti-aging skincare products and treatments. Additionally, Japan has a high disposable income per capita, allowing consumers to spend more on premium skincare products. The strong economy and stable consumer confidence further contribute to the growth of the market.In conclusion, the Skin Treatment market in Japan is experiencing growth due to changing customer preferences, including a focus on natural and organic products and multi-step skincare routines. The unique skincare culture in Japan, influenced by traditional practices, also contributes to the market's development. Furthermore, underlying macroeconomic factors such as the aging population and high disposable income per capita support the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.